Outlook
✓ Industry structural demand for SaaS, microservices, cloud and subscription-based services is strengthening
✓ COVID-19 has accelerated digital transformation
✓ Bravura is starting to see increasing market confidence as a result of vaccine rollouts in the UK
✓ As vaccines rollout, Bravura anticipates a resumption in UK and South Africa demand in FY22 from projects postponed due to COVID-19
✓ Bravura will emerge stronger as a result of the strategic initiatives and investment in R&D to develop componentisation of products during FY21
✓ Bravura is significantly increasing its total addressable market via the rollout of microservices
BVS Price at posting:
$3.76 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)